Mpox alerts updated for France and Angola: what travellers need to know
What happened
On 9 September 2026, NaTHNaC, the National Travel Health Network and Centre, updated its outbreak surveillance entries for mpox in two countries. France has reported 173 confirmed cases of clade Ib mpox as of 28 August 2026. Angola has reported 274 confirmed clade Ib cases over the same period. Both countries are listed at NaTHNaC's amber alert level, which means travellers are advised to take extra precautions. Amber is not a recommendation against travel. Mpox, previously called monkeypox, is a viral infection that spreads mainly through close physical contact, including skin-to-skin and sexual contact, and through contact with contaminated bedding, towels or clothing. It usually causes a rash or lesions, often with fever, headache, muscle aches and swollen glands. Most people recover within a few weeks, but it can be more serious in young children, pregnant women and people with weakened immune systems. Clade Ib is the strain that drove the outbreak declared a public health emergency of international concern by the World Health Organization, and it has since spread to a number of countries outside Africa. The presence of 173 confirmed cases in France is a reminder that this is no longer a distant issue for European travellers.
Why this matters
France is one of the most visited destinations for UK travellers, with millions of trips each year. When a country that close and that popular reports nearly 200 cases of a notifiable infection, it is worth knowing about, even if the personal risk to most holidaymakers is low. And it is low. Mpox does not spread easily through casual contact. You will not catch it walking past someone in a station or sitting near them in a café. It requires close, usually prolonged, physical contact. What this does affect is a smaller group of travellers with higher exposure: people who will have close physical or sexual contact with new partners, healthcare workers, and anyone visiting or caring for someone unwell. The Angola figure matters for a different reason. It is part of the wider clade Ib outbreak across parts of Africa, where health systems are under far more strain and where case numbers are likely undercounted. For travellers visiting friends and relatives, working in healthcare, or staying in shared accommodation, the practical advice is more relevant. There is also a reason to take this seriously that has nothing to do with fear: mpox is largely preventable, a vaccine exists, and knowing the symptoms means a case gets picked up early rather than passed on.
What the evidence actually says
A few points deserve care. Confirmed case numbers are always an undercount, in every country. They reflect who was tested, and mild cases in people who did not seek care will not appear. So 173 in France means at least 173, not exactly 173. Amber alert level is a call for extra precautions, not a warning against travel. NaTHNaC uses a graded system, and it is worth reading what the level actually says rather than reacting to the colour. On vaccination, the MVA-BN vaccine, used in the UK, is offered to specific groups at higher risk rather than to all travellers. Eligibility in the UK is set nationally and reviewed periodically. Evidence from the 2022 mpox outbreak found the vaccine gave substantial protection, and two doses give better and longer protection than one. If you think you might be eligible, a sexual health clinic is the place to ask. On severity, most people with clade Ib mpox recover without hospital treatment. The higher risk groups are the ones already named: young children, pregnant women and those who are immunosuppressed. And a note on the wider picture: earlier this month a global mpox vaccine stockpile opened, intended to speed up the supply of doses to countries facing outbreaks. That is a meaningful step, and it is a reminder that the response to clade Ib is active and ongoing rather than stalled.
Practical advice
For most travellers to France, no change to your plans is needed. For everyone, a few sensible steps. Know the symptoms. A new unexplained rash, spots, ulcers or blisters, particularly with fever, headache, aching muscles or swollen glands, is the pattern to look out for. It can start anywhere on the body, including the genitals and inside the mouth. Avoid close skin-to-skin contact with anyone who has an unexplained rash or who is unwell, and do not share bedding, towels or clothing with them. If you are likely to have close or sexual contact with new partners while away, that is the situation where mpox risk is meaningfully higher. Sexual health services can advise on vaccination eligibility, and it is a straightforward conversation. Check TravelHealthPro for your destination before you go. It carries country-specific advice and is updated as situations change. If you develop symptoms while abroad, seek local medical advice and avoid close contact with others until you have been assessed. If you develop symptoms after returning to the UK, contact NHS 111 or a sexual health clinic by phone first, and tell them where you have been. Ringing ahead rather than turning up matters, because it lets services see you safely. And travel insurance: make sure yours covers medical treatment abroad, and take your GHIC or EHIC for travel in Europe, which covers state-provided medically necessary treatment but is not a substitute for insurance.
What to know
NaTHNaC updated its mpox alerts on 9 September 2026. France has confirmed 173 clade Ib cases and Angola 274, both as of 28 August 2026, and both countries sit at amber alert level, meaning extra precautions rather than avoiding travel. Mpox spreads through close physical contact, including sexual contact, and through shared bedding, towels and clothing, not through casual proximity. Most people recover in a few weeks, with higher risk for young children, pregnant women and people who are immunosuppressed. Vaccination is offered to specific higher-risk groups, and sexual health clinics can advise on eligibility. Know the symptoms, avoid close contact with anyone who has an unexplained rash, check TravelHealthPro before you go, and phone ahead rather than turning up if you develop symptoms. Sources: NaTHNaC / TravelHealthPro, Outbreak Surveillance, updated 9 September 2026, https://travelhealthpro.org.uk/outbreaks ; World Health Organization, mpox information, https://www.who.int/news-room/fact-sheets/detail/mpox ; NHS, mpox, https://www.nhs.uk/conditions/mpox/ This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional.
Related articles
Heading to Kosovo? Large demonstrations are planned in Pristina this month
The Foreign, Commonwealth and Development Office updated its travel advice for Kosovo on 11 September 2026. The change was the addition of information about la…
Jordan travel advice has changed. What UK travellers should do now
The Foreign, Commonwealth and Development Office updated its travel advice for Jordan on 10 September 2026. Information about Iranian missile strikes on Jordan…
Nepal travel advice updated: what trekkers and visitors need to check now
The Foreign, Commonwealth and Development Office updated its travel advice for Nepal on 11 September 2026. Two things changed. The first was information about…